Lena M. Biehl

Kerpener Str. 62
Koeln, NW 50937, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

Impact of an antimicrobial stewardship intervention on carbapenem use in children with cancer.

Impact of an antimicrobial stewardship intervention on carbapenem use in children with cancer.

Journal: Infection

Published: February 09, 2026

Protocol of the LEONORA randomized clinical trial: Lower gastrointestinal symptom burden by prophylaxis with synbiotics after colorectal cancer surgery.

Protocol of the LEONORA randomized clinical trial: Lower gastrointestinal symptom burden by prophylaxis with synbiotics after colorectal cancer surgery.

Journal: BMC cancer

Published: January 05, 2026

Immunogenicity, reactogenicity, and safety to assess booster vaccinations with BNT162b2 or double-dose mRNA-1273 in adults ≥75 years (EU-COVAT-1-AGED)-final report.

Immunogenicity, reactogenicity, and safety to assess booster vaccinations with BNT162b2 or double-dose mRNA-1273 in adults ≥75 years (EU-COVAT-1-AGED)-final report.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: December 23, 2025

Immunogenicity, reactogenicity and safety to assess booster vaccinations with BNT162b2 or double-dose mRNA-1273 in adults ≥75 years (EU-COVAT-1-AGED) - final report.

Immunogenicity, reactogenicity and safety to assess booster vaccinations with BNT162b2 or double-dose mRNA-1273 in adults ≥75 years (EU-COVAT-1-AGED) - final report.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: December 23, 2025

All-cause mortality and risk factors for death in patients with Clostridioides difficile infections: a prospective multi-centre cohort study in six German university hospitals, 2016-2020.

All-cause mortality and risk factors for death in patients with Clostridioides difficile infections: a prospective multi-centre cohort study in six German university hospitals, 2016-2020.

Journal: The Journal of hospital infection

Published: October 10, 2025

Combined phage therapy and faecal microbiota transplantation to treat recurrent urinary tract infection: a case series.

Combined phage therapy and faecal microbiota transplantation to treat recurrent urinary tract infection: a case series.

Journal: Nature microbiology

Published: September 12, 2025

Clinical and Genomic Characterization of Recalcitrant Enterococcal Bacteremia: A Multicenter Prospective Cohort Study (VENOUS).

Clinical and Genomic Characterization of Recalcitrant Enterococcal Bacteremia: A Multicenter Prospective Cohort Study (VENOUS).

Journal: bioRxiv : the preprint server for biology

Published: April 16, 2025

Identifying patients at high risk for antibiotic treatment following hospital admission: a predictive score to improve antimicrobial stewardship measures.

Identifying patients at high risk for antibiotic treatment following hospital admission: a predictive score to improve antimicrobial stewardship measures.

Journal: Infection

Published: February 03, 2025

Clinical and Genomic Characterization of Recalcitrant Enterococcal Bacteremia: A Multicenter Prospective Cohort Study (VENOUS).

Clinical and Genomic Characterization of Recalcitrant Enterococcal Bacteremia: A Multicenter Prospective Cohort Study (VENOUS).

Journal: The Journal of infectious diseases

Published: January 21, 2025

Nonantimicrobial therapies for recurrent urinary tract infection in women: is there a place for faecal microbiota transfer?

Nonantimicrobial therapies for recurrent urinary tract infection in women: is there a place for faecal microbiota transfer?

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: December 17, 2024

Clinical heterogeneity and treatment outcomes of extrapulmonary tuberculosis in a low-incidence setting: insights from a prospective cohort study.

Clinical heterogeneity and treatment outcomes of extrapulmonary tuberculosis in a low-incidence setting: insights from a prospective cohort study.

Journal: Infection

Published: December 06, 2024

How can the gut microbiome be targeted to fight multidrug-resistant organisms?

How can the gut microbiome be targeted to fight multidrug-resistant organisms?

Journal: The Lancet. Microbe

Published: September 16, 2024

Showing 1-12 of 45

Last Updated: 09/26/2026